GH1 and inflammatory bowel disease: In conclusion, these studies suggest that the absence of SOCS2 is protective against bone loss typical of IBD and are consistent with the premise that increased osteoblast SOCS2 expression represents a critical mediator through which proinflammatory cytokines inhibit GH signaling and decrease osteoblast function and bone accrual.